🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
A Phase 1, first in human (FIH), single-centre, double-blind, randomized, p...
Status
Terminated
Location
HMR
Start Date
2022-04-14
Trial ID
NCT05323110
The goals of this clinical study are to learn more about the study drug, GS...
Status
Terminated
Location
Arizona Arthritis & Rheumatology Associates P.C.
Start Date
2023-09-28
Trial ID
NCT06031415
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Quotient Clinical
Start Date
2013-08
Trial ID
NCT01918735
This is a study to investigate the potential clinical benefit of trilacicli...
Status
Completed
Location
Genesis Cancer Center
Start Date
2015-06-26
Trial ID
NCT02499770
Treatments Being Tested
The purpose of this study is to investigate experimental medication BMS-986...
Status
Completed
Location
Local Institution - 0059
Start Date
2018-02-12
Trial ID
NCT03400332
Treatments Being Tested
This study will assess the safety, tolerability, immunogenicity, and pharma...
Status
Completed
Location
Research Site
Start Date
2022-07-12
Trial ID
NCT05452304
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Completed
Location
Profil Institut für Stoffwechselforschung
Start Date
2022-06-07
Trial ID
NCT05407961
Treatments Being Tested
This is a Phase I, first-in-human (FIH) study to assess the safety, tolerab...
Status
Terminated
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02712372
Treatments Being Tested
This is a double-blind, randomized, placebo- and active-controlled study in...
Status
Recruiting
Location
Nucleus Network
Start Date
2025-10-06
Trial ID
NCT07207954
Treatments Being Tested